Trillion Dollar Shot, Episode 1: Birth of a Blockbuster
Before Ozempic, Wegovy, Mounjaro and Zepbound, there was Lotte Bjerre Knudsen. In the 1990s, the young scientist at the Danish drug company Novo Nordisk was trying to unlock the key to a new technology for treating Type 2 diabetes. To her bosses, Lotte’s project, which focused on a hormone called GLP-1, looked like a…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The Journal. →
Introducing The Journal: Trillion Dollar Shot
Buy discount Ozempic here now click this link
Here's How the New Weight Loss Drugs Could Change Everything
Anglerfish, Gila Monsters, and the Origin of Weight Loss Drugs
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.